We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email :PharmaSources@imsinoexpo.com
Whatsapp :+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East
Monthly Production Capacity: 1000kg
Packaging Information: 25kg/drum 1kg/bottle
Delivery Lead Time: 7 days after payment
Sample Provided: yes
Payment Terms: L/L
Product Information
Product name
Febuxostat
CAS No.
144060-53-7
Molecular Formula
C16H16N2O3S
Molecular Weight
316.3748
Quality Standard
99% up by HPLC, EDMF
Appearance
White powder
COA of Febuxostat
ITEMS
SPECIFICATIONS
RESULTS
CHARACTERISTICS
A WHITE OR WHITE CRYSTALLINE POWDER
COMPLIES
IDENTIFICATION
POSITIVE
COMPLIES
SOLUBILITY OF SOLUTION
AND COLOUR
COMPLIES
COMPLIES
ASSAY(BY HPLC)
98%~102%
99.7%
RELATED IMPURITIES
NMT0.1%
0.1%
LOSS ON DRYING
NMT0.5%
0.2%
RESIDUE ON IGNITION
NMT0.2%
0.05%
HEAVY METALS
NMT0.001%
NMT0.001%
CONCLUSION:THE PRODUCT COMPLIES WITH EDMF STANDARD.
Usage
Function of Febuxostat
The main effect of febuxostat is to promote uric acid excretion and inhibit uric acid production.
At present, the drugs for the treatment of elevated uric acid in my country mainly include two categories: 1. Drugs that promote the excretion of uric acid, such as benzbromarone; 2. Drugs that inhibit the production of uric acid, the most representative of which is allopurinol. Febuxostat is a new type of uric acid-lowering drug with a similar mechanism of action to allopurinol, mainly inhibiting xanthinase, thereby inhibiting the production of uric acid. At the same time, febuxostat has less side effects and has less impact on liver and kidney function, especially patients with moderate or lower renal insufficiency can use febuxostat with confidence. At the same time, patients can achieve a good therapeutic effect on gout by cooperating with diet and strict low-purine diet.